What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Jeffrey M. Peters mainly focuses on Internal medicine, Endocrinology, Peroxisome proliferator-activated receptor, Peroxisome and Receptor.
His Internal medicine study combines topics from a wide range of disciplines, such as Nuclear receptor, Phthalate and Cell growth.
His Endocrinology study incorporates themes from Liver X receptor, Peroxisome proliferator-activated receptor delta, Peroxisome proliferator-activated receptor gamma and Carbohydrate-responsive element-binding protein.
His biological study spans a wide range of topics, including Carcinogen, Fatty acid-binding protein, Glucose homeostasis, Fibrate and Cell biology.
Jeffrey M. Peters has researched Peroxisome in several fields, including Carcinogenesis, Mechanism of action, Peroxisome proliferator-activated receptor alpha and Fatty acid.
His Receptor research includes elements of Cancer research, Transcription factor, Immunology, Ratón and Toxicity.
His most cited work include:
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting (1397 citations)
- The PPARalpha-leukotriene B4 pathway to inflammation control. (1209 citations)
- Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1 (935 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Peroxisome proliferator-activated receptor, Internal medicine, Endocrinology, Receptor and Cell biology.
The study incorporates disciplines such as Cell growth, Carcinogenesis, Peroxisome proliferator-activated receptor delta, Nuclear receptor and Peroxisome in addition to Peroxisome proliferator-activated receptor.
His Peroxisome research includes themes of Lipid metabolism and Fatty acid.
His study in Internal medicine is interdisciplinary in nature, drawing from both Fetus, Gene expression and Hepatocyte.
Jeffrey M. Peters has included themes like Inflammation, Toxicity, Peroxisome Proliferation and Peroxisome proliferator-activated receptor alpha in his Endocrinology study.
His Receptor research is multidisciplinary, relying on both Transcription factor, Pharmacology and Downregulation and upregulation.
He most often published in these fields:
- Peroxisome proliferator-activated receptor (50.43%)
- Internal medicine (48.71%)
- Endocrinology (47.41%)
What were the highlights of his more recent work (between 2013-2020)?
- Peroxisome proliferator-activated receptor (50.43%)
- Internal medicine (48.71%)
- Cancer research (16.81%)
In recent papers he was focusing on the following fields of study:
Jeffrey M. Peters mostly deals with Peroxisome proliferator-activated receptor, Internal medicine, Cancer research, Endocrinology and Receptor.
His Peroxisome proliferator-activated receptor research is multidisciplinary, incorporating perspectives in Cellular differentiation, Peroxisome proliferator-activated receptor delta, Nuclear receptor, Cell biology and Peroxisome.
In the field of Internal medicine, his study on Esophageal adenocarcinoma and Amphiregulin overlaps with subjects such as Esophagectomy and Vascular endothelial growth factor A.
Jeffrey M. Peters interconnects Cell culture, Cell, Epiregulin, Carcinogenesis and Cancer cell in the investigation of issues within Cancer research.
In the subject of general Endocrinology, his work in Choline is often linked to Wet age-related macular degeneration, thereby combining diverse domains of study.
His Receptor research incorporates elements of Toxicity, Mode of action, Cell growth and Aryl hydrocarbon receptor.
Between 2013 and 2020, his most popular works were:
- Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study. (132 citations)
- Lipid metabolism and lipophagy in cancer. (54 citations)
- The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions (51 citations)
In his most recent research, the most cited papers focused on:
Jeffrey M. Peters spends much of his time researching Cancer research, Peroxisome proliferator-activated receptor delta, Nuclear receptor, Signal transduction and Carcinogenesis.
His research in Cancer research intersects with topics in Internal medicine and Endocrinology.
His work deals with themes such as Liver cancer, Epidermal growth factor, Epiregulin and Mode of action, which intersect with Endocrinology.
The concepts of his Peroxisome proliferator-activated receptor delta study are interwoven with issues in Molecular biology, Cell and Peroxisome proliferator-activated receptor.
Jeffrey M. Peters combines subjects such as Inflammation and Cell growth with his study of Nuclear receptor.
As part of one scientific family, Jeffrey M. Peters deals mainly with the area of Carcinogenesis, narrowing it down to issues related to the Pharmacology, and often Receptor, Gemfibrozil, Toxicodynamics, Toxicity and Peroxisome proliferator-activated receptor alpha.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
